Form D · Pharmaceuticals
Phrixus Pharmaceuticals Inc
Ann Arbor, MI · CIK 0001408693
Offering snapshot reported Oct 8, 2013 · SEC filing
- Reported sold
- $100K Offering amount: $1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Sep 25, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 8, 2013 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Jan 5, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 31, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-204200
Source: Form D, filed Oct 8, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gerald Brennan | Director |
| Leslie Browne | Director |
| Thomas A Collet | Director, Executive |
| Bruce Markham | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1600 Huron Parkway Building 520 2 Nd Floor
Ann Arbor, MI, 48109
Ann Arbor, MI, 48109